Search Results

By Allan V. Espinosa, MD, and Manisha H. Shah, MD  / June 25, 2017

Major Breakthrough in Development of Systemic Targeted Therapy for Midgut Neuroendocrine Tumors

This issue of The ASCO Post discusses a recent trial reported by Strosberg et al in The New England Journal of Medicine that is the first phase III randomized international multicenter clinical trial evaluating lutetium Lu-177 dotatate as a peptide receptor radionuclide therapy in midgut...